SLAM BioTherapeutics, Inc.
SLAM BioTherapeutics, Inc. is a biotech company developing first-in-class human antibody-drug conjugates (ADCs) and bispecific monoclonal antibodies targeting blood cancers.
Funding history
About SLAM BioTherapeutics, Inc.
How much funding has SLAM BioTherapeutics, Inc. raised?
SLAM BioTherapeutics, Inc. has raised $8.2M in total funding. The most recent round was Seed.
Where is SLAM BioTherapeutics, Inc. headquartered?
SLAM BioTherapeutics, Inc. is headquartered in Thousand Oaks, CA.
What does SLAM BioTherapeutics, Inc. do?
SLAM BioTherapeutics, Inc. is a biotech company developing first-in-class human antibody-drug conjugates (ADCs) and bispecific monoclonal antibodies targeting blood cancers.
What makes SLAM BioTherapeutics, Inc. notable?
SLAM BioTherapeutics, an oncology biotech based in Westlake Village, CA, was co-founded by Dr. Steven T. Rosen, a prominent cancer researcher affiliated with City of Hope, alongside CEO Rick Heinick.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
